Opgen Inc (OPGN): Kevin Krenitsky , President of Opgen Inc purchased 43,716 shares on May 19, 2016. The Insider buying transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.00 per share for a total value of $0.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 23, 2016, Capital, Llc Jven (10% owner) purchased 874,317 shares at $0.00 per share price.On May 23, 2016, Evan/ Fa Jones (CEO) purchased 874,317 shares at $0.00 per share price.Also, On May 23, 2016, Timothy J.r. Harris (director) purchased 43,716 shares at $0.00 per share price.On May 23, 2016, Timothy C Dec (CFO) purchased 43,716 shares at $0.00 per share price.
Shares of OpGen Inc (OPGN) ended Friday, May 20, 2016 session in red amid volatile trading. The shares closed down -0.024 points or -1.91% at $1.23 with 12,837 shares getting traded. Post opening the session at $1.32, the shares hit an intraday low of $1.175 and an intraday high of $1.325 and the price vacillated in this range throughout the day. The company has a market cap of $15,476 M and the number of outstanding shares has been calculated to be 12,58,20,00,000 shares. The 52-week high of OpGen Inc is $4.85 and the 52-week low is $1.02.
OpGen Inc. is a United States-based Company that provides optical mapping solutions for life sciences. The Company offers optical mapping services for analysis of microbial yeast and fungal genomic architecture. It offers its optical mapping technology for life science clinical and food microbiology life science epidemiology pharmacology microbial forensics manufacturing quality control and applied research applications. Its map analysis software module includes with the Argus Whole Genome Mapping System which provides analysis for microbial samples and genomes up to 100Mb.